Cannabis May Ease Some Symptoms, but It Does Not Treat Plague
Plague is a serious infection caused by the bacterium Yersinia pestis. Although it is best known for the Black Death, plague still occurs sporadically in parts of the western United States and other regions where the bacterium circulates among wild rodents and fleas. People can become infected through the bite of an infected flea, contact with infected animals or tissues, or— in cases of pneumonic plague—exposure to respiratory droplets.
The main clinical forms are bubonic, septicemic, and pneumonic plague. Bubonic plague typically causes fever, chills, headache, weakness, and a painful swollen lymph node called a bubo. Septicemic plague occurs when the bacteria infect the bloodstream and may cause abdominal symptoms, bleeding, shock, or tissue damage. Pneumonic plague affects the lungs and can progress rapidly, causing shortness of breath, chest pain, cough, and bloody or frothy sputum.
Plague is a medical emergency, but it is treatable when recognized promptly. The Centers for Disease Control and Prevention’s clinical-care guidance recommends immediate antimicrobial treatment, with drug choice and route of administration determined by the patient’s condition and clinical form of disease. Patients with suspected pneumonic plague also require appropriate infection-control precautions because the illness can spread through respiratory droplets.
Cannabis-based medicines may help manage certain symptoms in some medical settings, including chronic pain, nausea, and spasticity. However, those findings do not show that cannabis treats plague or eliminates Y. pestis from the body. A systematic review of randomized clinical trials found limited or condition-specific evidence for cannabinoids in pain, spasticity, and nausea, while also documenting potential adverse effects. These studies did not evaluate cannabis as a treatment for plague.
Laboratory research has also found antibacterial activity for some cannabinoids, but the evidence is narrow and cannot be applied automatically to Y. pestis. For example, the 1976 study of THC and cannabidiol reported activity against several staphylococci and streptococci but found that gram-negative bacteria were resistant under the conditions tested. Because Y. pestis is a gram-negative bacterium, this study provides no evidence that THC or cannabidiol can treat plague. In addition, laboratory concentrations and formulations may not be safe, effective, or achievable in human patients.
For these reasons, cannabis should not be used as a substitute for antibiotics, supportive care, or public-health guidance. Anyone who develops a fever or other symptoms after possible exposure to infected rodents, fleas, or a person with pneumonic plague should seek urgent medical attention and disclose the exposure. Prevention measures described by the CDC’s plague information include avoiding contact with sick or dead wild animals, reducing rodent habitats around homes, using flea control, and following public-health advice after a suspected exposure.
Further research could examine whether specific cannabis-derived compounds have useful effects against particular bacteria or could complement established treatments. At present, however, there is no clinical evidence that medical cannabis cures Yersinia pestis infection. Its possible role is limited to symptom management under the supervision of a qualified clinician.
